The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans

Medical Mycology

Volumn 51, Issue 5, 2013, Pages 473-482

  Hsu, Chih Chieh ^a,b   Lai, Wen Lin ^c,d   Chuang, Kuei Chin ^a   Lee, Meng Hwan ^b,e   Tsai, Ying Chieh ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Yangsen Biotechnology Co Ltd   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e ANIMAL TECHNOLOGY INSTITUTE TAIWAN   (Taiwan)

Author keywords

Adhesin; Biofilm; Candida albicans; Linalool

Indexed keywords

ADHESIN; ALS3 PROTEIN; AMPHOTERICIN B; CPH1 PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYR1 PROTEIN; HWP1 PROTEIN; LINALOOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; RAS1 PROTEIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOARCHITECTURE; DOWN REGULATION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS HYPHAE; GENE EXPRESSION; GENE REPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION;

CANDIDA; CANDIDA ALBICANS;

EID: 84879898990     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.743051     Document Type: Article

References (50)

1. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267.
2. Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol 2010; 59: 227-238.
3. d'Enfert C. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents. Curr Drug Targets 2006; 7: 465-470.
4. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009; 35: 340-355.
5. Tampieri MP, Galuppi R, Macchioni F, et al. The inhibition of Candida albicans by selected essential oils and their major components. Mycopathologia 2005; 159: 339-345.
6. Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 2006; 6: 158.
7. Lambert RJ, Skandamis PN, Coote PJ, Nychas GJ. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J Appl Microbiol 2001; 91: 453-462.
8. Niu C, Gilbert ES. Colorimetric method for identifying plant essential oil components that affect biofilm formation and structure. Appl Environ Microbiol 2004; 70: 6951-6956.
9. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68: 5459-5463.
10. Statti GA, Conforti F, Sacchetti G, et al. C hemical and biological diversity of Bergamot (Citrus bergamia) in relation to environmental factors. Fitoterapia 2004; 75: 212-216.
11. D'Auria FD, Tecca M, Strippoli V, et al. Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Med Mycol 2005; 43: 391-396.
12. Letizia CS, Cocchiara J, Lalko J, Api AM. Fragrance material review on linalool. Food Chem Toxicol 2003; 41: 943-964.
13. Prashar A, Locke IC, Evans CS. Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif 2004; 37: 221-229.
14. Peana AT, D ' Aquila PS, Panin F, et al. Anti-infl ammatory activity of linalool and linalyl acetate constituents of essential oils. Phytomedicine 2002; 9: 721-726.
15. Peana AT, D ' Aquila PS, Chessa ML, et al. (-)-Linalool produces antinociception in two experimental models of pain. Eur J Pharmacol 2003; 460: 37-41.
16. Ghelardini C, Galeotti N, Salvatore G, Mazzanti G. Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med 1999; 65: 700-703.
17. Khan A, Ahmad A, Akhtar F, et al. Ocimum sanctum essential oil and its active principles exert their antifungal activity by disrupting ergosterol biosynthesis and membrane integrity. Res Microbiol 2010; 161: 816-823.
18. Zore GB, Thakre AD, Jadhav S, Karuppayil SM. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. Phytomedicine 2011; 18: 1181-1190.
19. Alviano WS, Mendonca-Filho RR, Alviano DS, et al. Antimicrobial activity of Croton cajucara Benth linalool-rich essential oil on artificial biofilms and planktonic microorganisms. Oral Microbiol Immunol 2005; 20: 101-105.
20. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 1999; 48: 671-679.
21. Clinical and Laboratory Standards Institute. Reference Method For Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard: M27-A3 ., 3rd edn. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2008.
22. Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Chemother 1997; 41: 1392-1395.
23. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-2479.
24. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001; 18: 163-170.
25. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327-335.
26. de Almeida ER, Rafael KR, Couto GB, Ishigami AB. Anxiolytic and anticonvulsant effects on mice of fl avonoids, linalool, and alphatocopherol presents in the extract of leaves of Cissus sicyoides L. (Vitaceae). J Biomed Biotechnol 2009; 2009: 274740.
27. Park SN, Lim YK, Freire MO, et al. Antimicrobial effect of linalool and alpha-terpineol against periodontopathic and cariogenic bacteria. Anaerobe 2012; 18: 369-372.
28. Thompson DS, Carlisle PL, Kadosh D. Coevolution of morphology and virulence in Candida species. Eukaryot Cell 2011; 10: 1173-1182.
29. Nobile CJ, Mitchell AP. Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol 2006; 8: 1382-1391.
30. Banerjee M, Thompson DS, Lazzell A, et al. UME6, a novel fi lamentspecific regulator of Candida albicans hyphal extension and virulence. Mol Biol Cell 2008; 19: 1354-1365.
31. Martin R, Moran GP, Jacobsen ID, et al. The Candida albicans - specific gene EED1 encodes a key regulator of hyphal extension. PLoS One 2011; 6: e18394.
32. Zheng X, Wang Y. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J 2004; 23: 1845-1856.
33. Liu H, Kohler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994; 266: 1723-1726.
34. Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 1998; 42: 1900-1905.
35. Braga PC, Culici M, Alfi eri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents 2008; 31: 472-477.
36. Dalleau S, Cateau E, Berges T, Berjeaud JM, Imbert C. I n vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents 2008; 31: 572-576.
37. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006; 5: 1604-1610.
38. Nobile CJ, Schneider HA, Nett JE, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 2008; 18: 1017-1024.
39. Sundstrom P, Balish E, Allen CM. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J Infect Dis 2002; 185: 521-530.
40. Liu Y, Filler SG. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 2011; 10: 168-173.
41. Phan QT, Myers CL, Fu Y, et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 2007; 5: e64.
42. Manohar V, Ingram C, Gray J, et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 2001; 228: 111-117.
43. Braga PC, Alfi eri M, Culici M, Dal Sasso M. Inhibitory activity of thymol against the formation and viability of Candida albicans hyphae. Mycoses 2007; 50: 502-506.
44. Ahmad A, Khan A, Akhtar F, et al. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 2011; 30: 41-50.
45. Hammer KA, Carson CF, Riley TV. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 2004; 53: 1081-1085.
46. Roman E, Alonso-Monge R, Gong Q, et al. The Cek1 MAPK is a short-lived protein regulated by quorum sensing in the fungal pathogen Candida albicans. FEMS Yeast Res 2009; 9: 942-955.
47. Sato T, Watanabe T, Mikami T, Matsumoto T. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol Pharm Bull 2004; 27: 751-752.
48. Hall RA, Turner KJ, Chaloupka J, et al. The quorum-sensing molecules farnesol/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans. Eukaryot Cell 2011; 10: 1034-1042.
49. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 2008; 67: 47-62.
50. Cao YY, Cao YB, Xu Z, et al. c DNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 2005; 49: 584-589.